Harvard Apparatus Regenerative Technology Inc. posts Q3 revenue of $20.6 million with 58.4% gross margin

Reuters

Nov 06, 2025

<a href="https://laohu8.com/S/HRGN">Harvard Apparatus Regenerative Technology Inc.</a> posts Q3 revenue of $20.6 million with 58.4% gross margin

Harvard Apparatus Regenerative Technology Inc. reported third quarter 2025 revenue of $20.6 million, compared to $22.0 million in the same period last year. Gross margin was $12.0 million or 58.4% of revenue, up from 58.1% a year earlier. Adjusted EBITDA rose to $2.0 million from $1.3 million in the prior year quarter. The company recorded operating income of $0.2 million, compared to an operating loss of $1.9 million last year. Cash provided by operations reached $6.8 million, an increase from negative $0.3 million in the same period of 2024. The company cited strong demand, the highest backlog in nearly two years, and ongoing discussions regarding refinancing or repayment of its existing credit agreement. Fourth quarter 2025 guidance projects revenue between $22.5 million and $24.5 million, with gross margin expected between 58% and 60%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Apparatus Regenerative Technology Inc. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2581067273"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2581067273\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2581067273?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-06 20:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581067273","market":"us","top_or_hot":-1,"title":"Harvard Apparatus Regenerative Technology Inc. posts Q3 revenue of $20.6 million with 58.4% gross margin","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/HRGN\">Harvard Apparatus Regenerative Technology Inc.</a> posts Q3 revenue of $20.6 million with 58.4% gross margin\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Harvard Apparatus Regenerative Technology Inc. reported third quarter 2025 revenue of $20.6 million, compared to $22.0 million in the same period last year. Gross margin was $12.0 million or 58.4% of revenue, up from 58.1% a year earlier. Adjusted EBITDA rose to $2.0 million from $1.3 million in the prior year quarter. The company recorded operating income of $0.2 million, compared to an operating loss of $1.9 million last year. Cash provided by operations reached $6.8 million, an increase from negative $0.3 million in the same period of 2024. The company cited strong demand, the highest backlog in nearly two years, and ongoing discussions regarding refinancing or repayment of its existing credit agreement. Fourth quarter 2025 guidance projects revenue between $22.5 million and $24.5 million, with gross margin expected between 58% and 60%.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Apparatus Regenerative Technology Inc. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Harvard Apparatus Regenerative Technology Inc. posts Q3 revenue of $20.6 million with 58.4% gross margin</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHarvard Apparatus Regenerative Technology Inc. posts Q3 revenue of $20.6 million with 58.4% gross margin\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-06 20:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/HRGN\">Harvard Apparatus Regenerative Technology Inc.</a> posts Q3 revenue of $20.6 million with 58.4% gross margin\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Harvard Apparatus Regenerative Technology Inc. reported third quarter 2025 revenue of $20.6 million, compared to $22.0 million in the same period last year. Gross margin was $12.0 million or 58.4% of revenue, up from 58.1% a year earlier. Adjusted EBITDA rose to $2.0 million from $1.3 million in the prior year quarter. The company recorded operating income of $0.2 million, compared to an operating loss of $1.9 million last year. Cash provided by operations reached $6.8 million, an increase from negative $0.3 million in the same period of 2024. The company cited strong demand, the highest backlog in nearly two years, and ongoing discussions regarding refinancing or repayment of its existing credit agreement. Fourth quarter 2025 guidance projects revenue between $22.5 million and $24.5 million, with gross margin expected between 58% and 60%.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Apparatus Regenerative Technology Inc. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL5tzygS:1","article_id":"2581067273","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2581067273","pubTimestamp":1762431789,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Harvard Apparatus Regenerative Technology Inc. reported third quarter 2025 revenue of $20.6 million, compared to $22.0 million in the same period last year. Gross margin was $12.0 million or 58.4% of revenue, up from 58.1% a year earlier. Adjusted EBITDA rose to $2.0 million from $1.3 million in the prior year quarter. The company recorded operating income of $0.2 million, compared to an operating loss of $1.9 million last year. Cash provided by operations reached $6.8 million, an increase from negative $0.3 million in the same period of 2024. The company cited strong demand, the highest backlog in nearly two years, and ongoing discussions regarding refinancing or repayment of its existing credit agreement. Fourth quarter 2025 guidance projects revenue between $22.5 million and $24.5 million, with gross margin expected between 58% and 60%.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","HRGN":"Harvard Apparatus Regenerative Technology Inc."},"translate_title":"Harvard Apparatus Regenerative Technology Inc.第三季度营收为2060万美元，毛利率为58.4%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HRGN":0.9},"content_text":"Harvard Apparatus Regenerative Technology Inc. posts Q3 revenue of $20.6 million with 58.4% gross margin\n    \n\n        Harvard Apparatus Regenerative Technology Inc. reported third quarter 2025 revenue of $20.6 million, compared to $22.0 million in the same period last year. Gross margin was $12.0 million or 58.4% of revenue, up from 58.1% a year earlier. Adjusted EBITDA rose to $2.0 million from $1.3 million in the prior year quarter. The company recorded operating income of $0.2 million, compared to an operating loss of $1.9 million last year. Cash provided by operations reached $6.8 million, an increase from negative $0.3 million in the same period of 2024. The company cited strong demand, the highest backlog in nearly two years, and ongoing discussions regarding refinancing or repayment of its existing credit agreement. Fourth quarter 2025 guidance projects revenue between $22.5 million and $24.5 million, with gross margin expected between 58% and 60%.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Apparatus Regenerative Technology Inc. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}